3D Bioprinting Possibilities and Challenges

View PDF
Human mesenchymal stem cells (hMSCs) on Corning Synthemax II polystyrene microcarriers (WWW.CORNING.COM)

Human mesenchymal stem cells (hMSCs) on Corning Synthemax II polystyrene microcarriers (WWW.CORNING.COM)

Three-dimensional (3D) bioprinting is the newest addition to the regenerative medicine family. Now within the industry dedicated to providing more personalized drug products, this new additive-manufacturing technology has the potential to truly focus on individual tissue repair and replacement. In a short period of time, 3D bioprinting has been applied in studies using bones, blood vessels, composite tissues, vascular grafts, tracheal splints, cartilaginous structures, heart tissue (e.g., two-valve heart), and vaginal organs (1).

View the full article below – Login Required

Please log in to access this content.

References
1
Yoo J. Current Developments and Clinical Perspectives of Bioprinting Technology. Biotech Week Boston: 7 October 2016.

2 Szczerba RJ. No Donor Required: 5 Body Parts You Can Make With 3-D Printers. Forbes 17 June 2015.

3 Chartrain N, Williams CB, Whittington AR. Engineering Tissues with Bioprinting. BioProcess Int. 14(10) 2016: 28–33.

4 Wang M, et al. The Trend Towards In Vivo Bioprinting. ResearchGate July 2015; doi: 10.18063/IJB.2015.01.001.

5 Chung J. Bio-Ink Properties and Printability for Extrusion Printing. Liv. Cells. Biomater. Sci. 1, 2013: 763–773; doi: 10.1039/C3BM00012E.

6 Nishiyama Y, et al. Ink Jet Three-Dimensional Digital Fabrication for Biological Tissue Manufacturing: Analysis of Alginate Microgel Beads Produced by Ink Jet Droplets for Three Dimensional Tissue Fabrication. J. Imaging Sci. Technol. 52(6) 2008.

7 Ozbolat IT. Scaffold-Based or Scaffold-Free Bioprinting: Competing or Complementing Approaches? J. Nanotechnol. Eng. Med. 6 2015; doi: 0.1115/1.4030414.

8 Norotte C, et al. Scaffold-Free Vascular Tissue Engineering Using Bioprinting. Biomaterials 30(30) 2009: 5910–5917; doi: 10.1016/j.biomaterials.2009.06.034.

9 Mironov V, Kasyanov V, Markwald RR. Organ Printing: From Bioprinter to Organ Biofabrication Line. Curr. Op. Biotechnol. 22(5) 2011: 667–673.

10 Miller JS. The Billion Cell Construct: Will ThreeDimensional Printing Get Us There? PLOS Biology June 2017; http://journals.plos.org/plosbiology/article?id=10.1371/journal. pbio.1001882.

11 Organovo’s Bioprinting Platform: Enabling 3D, Architecturally Correct, Fully Human Tissue for Drug Discovery and Transplantation. Cell and Gene Meeting: La Jolla, CA, October 2016.

12 Kolesky D. Biotech Week Boston: 4–7 October 2016.

13 Homan KA, et al. Bioprinting of 3D Convoluted Renal Proximal Tubules on Perfusable Chips. Sci. Rep. 11(6) 2016: 34845. doi: 10.1038/srep34845.

14 Yu Y, Zhang, Y, Ozbolat IT. Evaluation of Cell Viability and Functionality in Vessel-Like Bioprintable CellLaden Tubular Channels. J. Biomech. Eng. 135(9) 2013; doi:10.1115/1.4024575.

15 Kolesky D, et al. 3D Bioprinting of Vascularized, Heterogeneous Cell-Laden Tissue Constructs. Adv. Materials 26(19) 2014: 3124–3130; doi: 10.1002/adma.201305506.

16 Lee VK, et al. Creating Perfused Functional Vascular Channels Using 3D Bioprinting Technology. Biomaterials 35(28) 2014: 8092–8102.

17 Grigoryan B, Miller J. The Ambitious Future of Tissue Engineering. Democratizing Cell Technologies 3 January 2017. http://roosterbio.blogspot.com.

18 Squillaro T, Peluso G, Galderisi U. Clinical Trials with Mesenchymal Stem Cells: An Update. Cell Transplant. 25(5) 2016: 829–848.

19 Nguyen DG. Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro. PLOS One 7 July 2016; http://dx. doi.org/10.1371/journal.pone.015867.

Maribel Rios is managing editor of BioProcess International; mrios@bioprocessintl.com.

Leave a Reply